14.11.2024 • News
AstraZeneca to Invest $3.5 Billion in the US
Anglo-Swedish drugmaker AstraZeneca plans to invest $3.5 billion in the US to expand the company’s research and manufacturing footprint by the end of 2026.
investment
12.11.2024 • News
Nouryon Completes Expansion for Organic Peroxides in China
Dutch specialty chemicals producer Nouryon has completed the capacity expansion for organic peroxides at its manufacturing facility in Ningbo, China. The expansion doubled production capacity to 6,000 tons of organic peroxide products each, which are sold under the Perkadox 14 and Trigonox 101 brands.
12.11.2024 • News • Bioprocessing
Lonza to Expand Bioconjugation in Visp, Switzerland
Lonza, a global contract development and manufacturing organization (CDMO) for the pharmaceutical, biotech, and nutraceutical markets, announced today that it will invest in additional bioconjugation capabilities in Visp, Switzerland.
11.11.2024 • News
Evonik to Expand Specialty Amine Production in Nanjing, China
German specialty chemicals group Evonik broke ground on its plant expansion for specialty amines at its site Nanjing, China, on Nov. 8. Construction work is expected to be completed in 2026.
08.11.2024 • News
SABIC Opens Multi-Million-Dollar Resin Manufacturing Facility in Singapore
SABIC recently announced the official launch of its new US$170 (€157.7) million ultem resin manufacturing facility in Singapore, marking the company’s first advanced specialty chemical manufacturing facility in the region producing the high-performance thermoplastic, ultem resin.
05.11.2024 • News
Ardena Expands European Bioanalytical Capabilities
Belgium-headquartered pharmaceutical contract development and manufacturing organization (CDMO) Ardena announced plans to expand its bioanalytical services in the Netherlands. As part of the investment, the company plans to establish a new bioanalytical laboratory at its Pivot Park facility in Oss, as well as additional capacity and new GLP capabilities at its bioanalytical center of excellence in Assen.
31.10.2024 • News • Bioprocessing
Sterling Pharma Solutions Expands GMP ADC Manufacturing Capacity
Sterling Pharma Solutions, a global contract development and manufacturing organization (CDMO), today announced the second phase of an expansion strategy at its Deeside, UK site to support antibody-drug conjugate (ADC) development, with a more than £10 million (€11.9 million) investment to increase GMP bioconjugation capacity.
29.10.2024 • News
GSK to Invest $800 Million in US Manufacturing Facility
British pharma company GlaxoSmithKline (GSK) plans to invest up to $800 million to expand drug substance and drug product manufacturing capabilities at the company’s US site in Marietta, Pennsylvania. The investment, which GSK said is its largest ever in US manufacturing, is expected to create more than 200 new jobs.
25.10.2024 • News
Eni to Invest €2 Billion in the Transformation and Relaunch of Versalis
Italian energy group Eni has finalized its transformation and relaunch plan for Versalis, its chemicals business. As part of the plan, Eni will invest about €2 billion to reduce emissions by approximately 1 million t of CO2, currently about 40% of Versalis' emissions in Italy.
25.10.2024 • News
Rentschler Plans New Buffer Media Facility at its Headquarters
In a move to further increase production efficiency and modernize the site, German contract development and manufacturing organization (CDMO) Rentschler Biopharma plans to construct a new buffer media station at its company headquarters in Laupheim. According to Rentschler, this is the largest single investment in the German site.
23.10.2024 • News
Avantium Opens Biobased FDCA Plant in the Netherlands
Dutch renewables specialist Avantium has officially opened its FDCA (furandicarboxylic acid) flagship plant in Delfzijl, the Netherlands. Plans for what was said to be the world's first commercial-scale production plant for FDCA were first announced in December 2021.
17.10.2024 • News
Cambrex Opens New Stability Storage Facility
Today, Cambrex announced its stability storage business, Q1 Scientific, and opened a new cGMP facility in Durham, North Carolina, expanding its capacity for environmentally controlled stability storage services to North America's pharmaceutical, medical device, and life sciences industries.
04.10.2024 • News
Piramal to Expand US Facility for Sterile Injectables
US contract development and manufacturing organization (CDMO) Piramal Pharma Solutions (PPS), part of India-headquartered Piramal Pharma, plans to invest $80 million for the expansion of its Lexington, Kentucky, facility.
03.10.2024 • News • Bioprocessing
Lilly Announces New $4.5 Billion Site
Eli Lilly and Company (Lilly) recently announced a $4.5 billion (€4.07 billion) investment to create the Lilly Medicine Foundry, a new center for advanced manufacturing and drug development.
03.10.2024 • News
SK Pharmteco to Expand Production in South Korea
South Korean contract development and manufacturing organization (CDMO) SK Pharmteco announced a major expansion of its small molecule and peptide production capabilities with a $260 million investment to construct a new facility in Sejong, South Korea.
02.10.2024 • News
A.P. Moller Holding Launches Fossil-free Plastic Resins Business
A.P. Moller Holding, the mother company of shipping giant Maersk, has launched Vioneo, a manufacturer of fossil-free plastic resins and intends to establish its first production complex in Antwerp, Belgium. The plant, in which Vioneo plans to invest €1,5 billion, will benefit from the region’s expertise in the chemicals industry, strong export facilities and access to renewable energy, the company said.
02.10.2024 • News
Evonik Breaks Ground on Major Silica Expansion in Charleston, US
Evonik recently announced the groundbreaking of a significant expansion at its Charleston site in South Carolina’s Berkeley County.
02.10.2024 • News
Lonza Completes Acquisition of Vacaville Biologics Site from Roche
Lonza has completed its acquisition of the Genentech large-scale biologics manufacturing site in Vacaville, California, USA, from Roche for $1.2 billion. The deal was announced in March of this year.
01.10.2024 • News
Carbon Waters Opens its First Production Unit
Carbon Waters recently reached a major milestone with the installation of its first production unit at its facility in Pessac.
30.09.2024 • News
Boehringer Ingelheim Expands Cancer Research at Vienna Site
On Sep. 25, German biopharma company Boehringer Ingelheim opened its new 11,000 sqm Angelika Amon Research Building at its site in Vienna, Austria. According to Boehringer Ingelheim, the investment of around €60 million is further proof of the company's commitment to cancer research.
20.09.2024 • News
Lonza Launches Innovaform Accelerator
Lonza inaugurated its new facility at the Colmar, France site. The new Innovaform Accelerator will serve as a Center of Excellence for developing and innovating capsule-based manufacturing and delivery solutions for oral and pulmonary administration.
19.09.2024 • News
Covestro to Build New TPU Center in China
Covestro will start the construction of a new Thermoplastic Polyurethanes (TPU) APAC Application Development (AD) Center in Guangzhou, China.
11.09.2024 • News
Nouryon Begins Operations in Mato Grosso do Sul, Brazil
Nouryon recently announced it has commenced operations at its new Integrated Manufacturing Model site in Ribas do Rio Pardo, Mato Grosso do Sul, Brazil, which includes the production of hydrogen peroxide, sodium chlorate, and chlorine dioxide.
Chemical Labor Productivity Challenge
The chemical industry faces acute labor shortages because the talent pool is shrinking, but the industry remains heavily reliant on manual work. Therefore, realizing labor productivity potential will be decisive for business continuity and future growth.
10.09.2024 • News
Serán More Than Doubles Clinical Manufacturing Capacity
CDMO Serán BioScience recently announced that it has completed an expansion to increase the number of process manufacturing suites at its facility in Bend, Oregon, from 6 to 14, adding approximately 130% more cGMP clinical manufacturing capacity.
09.09.2024 • News
Lonza Completes Expansion of Microbial Manufacturing Facility
Lonza recently announced that it has completed a planned expansion of the mid-scale microbial manufacturing facility at its Visp, Switzerland site. This multi-product facility was recently granted a GMP license, allowing cGMP manufacturing and release of biologics produced using microbial fermentation.
05.09.2024 • News
ADNOC Acquires Stake in ExxonMobils’s Texas Hydrogen Plant
Abu Dhabi National Oil Company (ADNOC) has agreed to acquire a 35% equity stake in ExxonMobil’s proposed low-carbon hydrogen and ammonia production facility in Baytown, Texas, US.
03.09.2024 • News
Evonik Completes Expansion of Methionine Production in Singapore
Evonik has completed the expansion of its MetAmino (DL-methionine) production facilities in Singapore and the production on Jurong Island is again running at full capacity, after shutdowns in the fourth quarter of 2023 and the second quarter of 2024.
03.09.2024 • News
QatarEnergy to Build Urea Complex at Mesaieed
QatarEnergy has decided to build a new, world-scale urea production complex in Mesaieed Industrial City. The project comprises the construction of three ammonia production lines that will supply feedstock to four new urea production trains at the site.
29.08.2024 • News
BASF Coatings Opens New Application and Technical Center in China
BASF's Coatings division has inaugurated its new application and technical center in Jiangmen, China, which is located within the site of BASF Coatings (Guangdong) (BCG).
29.08.2024 • News
Wanhua Launches Citral Plant in China
Chinese chemical group Wanhua has launched its 48,000-ton-per-year citral production facility in Yantai, China.
22.08.2024 • News
Novo Nordisk Pharmatech to Build New Factory in Denmark
In order to meet significantly higher demand from its parent company Novo Nordisk, Novo Nordisk Pharmatech is planning to build a new factory at a 47,000 m² site in Køge, Denmark, which it acquired in March 2023.
19.08.2024 • News
Symrise Opens New Office and Lab Site in Beijing
In a move to enhance its R&D capabilities, customer proximity, and market presence in the North of China, German flavors and fragrances manufacturer Symrise has opened a new office and lab facility for food & beverage in Beijing.
15.08.2024 • News
Chemours Opens Battery Innovation Center in US
US chemical company Chemours has opened its Chemours Battery Innovation Center (CBIC), a laboratory facility located at the company’s Discovery Hub in Newark, Delaware, US. A multi-million-dollar investment, the CBIC supports the testing and scaling of next generation battery technologies, to enable more sustainable, cost-effective, energy-efficient, and high-performing batteries for hybrid and electric vehicles (EVs), Chemours said.
09.08.2024 • News
Pfizer Invests $100 Million to Upgrade Australian Site
Pfizer is investing nearly $100 million in a major upgrade to its manufacturing facility in Melbourne, Australia, that is intended to produce new antimicrobial treatments to address rising levels of antimicrobial resistance.
